Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 18
2003 20
2004 30
2005 23
2006 16
2007 16
2008 19
2009 23
2010 19
2011 19
2012 24
2013 22
2014 11
2015 12
2016 13
2017 20
2018 27
2019 26
2020 35
2021 23
2022 12
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Results by year

Filters applied: . Clear all
Page 1
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG. Goodman SG, et al. Among authors: zeiher am. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 24:pvae025. doi: 10.1093/ehjcvp/pvae025. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193
Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES.
Szarek M, Reijnders E, Steg PG, Jukema JW, Schwertfeger M, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Zeiher AM, Cobbaert C, Schwartz GG. Szarek M, et al. Among authors: zeiher am. Eur J Prev Cardiol. 2024 Mar 19:zwae110. doi: 10.1093/eurjpc/zwae110. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38501249 No abstract available.
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts.
Shumliakivska M, Luxán G, Hemmerling I, Scheller M, Li X, Müller-Tidow C, Schuhmacher B, Sun Z, Dendorfer A, Debes A, Glaser SF, Muhly-Reinholz M, Kirschbaum K, Hoffmann J, Nagel E, Puntmann VO, Cremer S, Leuschner F, Abplanalp WT, John D, Zeiher AM, Dimmeler S. Shumliakivska M, et al. Among authors: zeiher am. Nat Commun. 2024 Jan 19;15(1):606. doi: 10.1038/s41467-023-43003-w. Nat Commun. 2024. PMID: 38242884 Free PMC article.
Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.
Kattih B, Boeckling F, Shumliakivska M, Tombor L, Rasper T, Schmitz K, Hoffmann J, Nicin L, Abplanalp WT, Carstens DC, Arsalan M, Emrich F, Holubec T, Walther T, Puntmann VO, Nagel E, John D, Zeiher AM, Dimmeler S. Kattih B, et al. Among authors: zeiher am. Cardiovasc Res. 2023 Nov 25;119(15):2550-2562. doi: 10.1093/cvr/cvad140. Cardiovasc Res. 2023. PMID: 37648651
Aging impairs the neurovascular interface in the heart.
Wagner JUG, Tombor LS, Malacarne PF, Kettenhausen LM, Panthel J, Kujundzic H, Manickam N, Schmitz K, Cipca M, Stilz KA, Fischer A, Muhly-Reinholz M, Abplanalp WT, John D, Mohanta SK, Weber C, Habenicht AJR, Buchmann GK, Angendohr S, Amin E, Scherschel K, Klöcker N, Kelm M, Schüttler D, Clauss S, Günther S, Boettger T, Braun T, Bär C, Pham MD, Krishnan J, Hille S, Müller OJ, Bozoglu T, Kupatt C, Nardini E, Osmanagic-Myers S, Meyer C, Zeiher AM, Brandes RP, Luxán G, Dimmeler S. Wagner JUG, et al. Among authors: zeiher am. Science. 2023 Aug 25;381(6660):897-906. doi: 10.1126/science.ade4961. Epub 2023 Aug 24. Science. 2023. PMID: 37616346
Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques.
von Scheidt M, Bauer S, Ma A, Hao K, Kessler T, Vilne B, Wang Y, Hodonsky CJ, Ghosh SKB, Mokry M, Gao H, Kawai K, Sakamoto A, Kaiser J, Bongiovanni D, Fleig J, Oldenbuettel L, Chen Z, Moggio A, Sager HB, Hecker JS, Bassermann F, Maegdefessel L, Miller CL, Koenig W, Zeiher AM, Dimmeler S, Graw M, Braun C, Ruusalepp A, Leeper NJ, Kovacic JC, Björkegren JLM, Schunkert H. von Scheidt M, et al. Among authors: zeiher am. medRxiv [Preprint]. 2023 Jul 26:2023.07.22.23292754. doi: 10.1101/2023.07.22.23292754. medRxiv. 2023. PMID: 37546840 Free PMC article. Preprint.
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome.
Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, Morais J, Pordy R, Scemama M, White HD, Schwartz GG; ODYSSEY OUTCOMES Investigators. Steg PG, et al. Among authors: zeiher am. Can J Cardiol. 2023 Oct;39(10):1315-1324. doi: 10.1016/j.cjca.2023.04.018. Epub 2023 Apr 26. Can J Cardiol. 2023. PMID: 37116789 Free article.
Cardiomyocyte hyperplasia and immaturity but not hypertrophy are characteristic features of patients with RASopathies.
Drenckhahn JD, Nicin L, Akhouaji S, Krück S, Blank AE, Schänzer A, Yörüker U, Jux C, Tombor L, Abplanalp W, John D, Zeiher AM, Dimmeler S, Rupp S. Drenckhahn JD, et al. Among authors: zeiher am. J Mol Cell Cardiol. 2023 May;178:22-35. doi: 10.1016/j.yjmcc.2023.03.003. Epub 2023 Mar 21. J Mol Cell Cardiol. 2023. PMID: 36948385 Free article.
390 results